Literature DB >> 15135367

Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.

Dirk-Jan Slebos1, Dirkje S Postma, Gerard H Koëter, Wim Van Der Bij, Marike Boezen, Henk F Kauffman.   

Abstract

BACKGROUND: The detection of graft rejection by bronchoalveolar lavage remains controversial.
METHODS: To assess the value of bronchoalveolar lavage fluid in acute and chronic rejection after lung transplantation we analyzed bronchoalveolar lavage fluid cellular differential characteristics, lymphocyte sub-types and interleukin-6 (IL-6) and interleukin-8 (IL-8) cytokine levels in patients with exclusively either acute rejection (n = 37) or bronchiolitis obliterans (BO; n = 48). Both groups were compared with a control group of lung transplantation patients without rejection or infection, matched for the time the lavage was performed after lung transplantation.
RESULTS: The bronchiolitis obliterans group showed marked neutrophilia, high IL-8 and higher CD4(+)CD25(+) and CD8(+)CD45(+) bronchoalveolar lavage fluid levels when compared with their stable controls. When using a cut-off point of >3% neutrophils in the lavage, the sensitivity for BO is 87.0%, the specificity 77.6%. The sensitivity of IL-8 for BO when using a cut-off point of >71.4 pg/ml is 74.5%, the specificity 83.3%. Bronchoalveolar lavage fluid in acute rejection was characterized by marked lymphocytosis, but showed no difference when compared with stable controls in any of the lymphocyte sub-types studied. When using a cut-off point of <==1% lymphocytes in the lavage, the sensitivity for acute rejection (AR) is 40.4%, the specificity 95.6%. The marked neutrophilia, high IL-8 cytokine level and more activated lymphocyte population in bronchiolitis obliterans may indicate ongoing local allograft rejection.
CONCLUSIONS: In the present study we were not able to show any difference in lymphocyte sub-types when comparing acute rejection and control subjects. Cellular and soluble parameters in bronchoalveolar lavage fluid appear useful for diagnosing bronchiolitis obliterans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15135367     DOI: 10.1016/j.healun.2003.07.004

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  17 in total

Review 1.  Novel insights into lung transplant rejection by microarray analysis.

Authors:  Jeffrey D Lande; Jagadish Patil; Na Li; Todd R Berryman; Richard A King; Marshall I Hertz
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  CD4+ T lymphocytes are not necessary for the acute rejection of vascularized mouse lung transplants.

Authors:  Andrew E Gelman; Mikio Okazaki; Jiaming Lai; Christopher G Kornfeld; Friederike H Kreisel; Steven B Richardson; Seiichiro Sugimoto; Jeremy R Tietjens; G Alexander Patterson; Alexander S Krupnick; Daniel Kreisel
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

3.  Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection.

Authors:  Aric L Gregson; Aki Hoji; Rajan Saggar; David J Ross; Bernard M Kubak; Beth D Jamieson; S Samuel Weigt; Joseph P Lynch; Abbas Ardehali; John A Belperio; Otto O Yang
Journal:  Transplantation       Date:  2008-04-15       Impact factor: 4.939

Review 4.  Immunosuppression and allograft rejection following lung transplantation: evidence to date.

Authors:  Gregory I Snell; Glen P Westall; Miranda A Paraskeva
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

5.  Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome.

Authors:  John A Belperio; Michael P Keane; Marie D Burdick; Brigitte Gomperts; Ying Ying Xue; Kurt Hong; Javier Mestas; Abbas Ardehali; Borna Mehrad; Rajan Saggar; Joseph P Lynch; David J Ross; Robert M Strieter
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Bronchiolitis obliterans syndrome susceptibility and the pulmonary microbiome.

Authors:  Cody Schott; S Samuel Weigt; Benjamin A Turturice; Ahmed Metwally; John Belperio; Patricia W Finn; David L Perkins
Journal:  J Heart Lung Transplant       Date:  2018-04-26       Impact factor: 10.247

7.  Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.

Authors:  P Marco Fisichella; Christopher S Davis; Erin Lowery; Luis Ramirez; Richard L Gamelli; Elizabeth J Kovacs
Journal:  J Am Coll Surg       Date:  2013-04-28       Impact factor: 6.113

8.  Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.

Authors:  Deepti Saini; Nataraju Angaswamy; Venkataswarup Tiriveedhi; Naohiko Fukami; Sabarinathan Ramachandran; Ramsey Hachem; Elbert Trulock; Brian Meyers; Alexander Patterson; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2010-08-05       Impact factor: 10.247

Review 9.  Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome.

Authors:  V E Kennedy; J L Todd; S M Palmer
Journal:  Am J Transplant       Date:  2013-01-28       Impact factor: 8.086

10.  Shedding of Syndecan-1/CXCL1 Complexes by Matrix Metalloproteinase 7 Functions as an Epithelial Checkpoint of Neutrophil Activation.

Authors:  Sean E Gill; Samuel T Nadler; Qinglang Li; Charles W Frevert; Pyong Woo Park; Peter Chen; William C Parks
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.